APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Placenta Growth Factor

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Placenta Growth Factor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174026170322 December 2025180 pages

Choose your research edition.

Industry ResearchPlacenta Growth Factor Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Placenta Growth Factor Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Placenta Growth Factor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Placenta Growth Factor Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Placenta Growth Factor Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Placenta Growth Factor market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Placenta Growth Factor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Placenta Growth Factor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Placenta Growth Factor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Placenta Growth Factor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Placenta Growth Factor include Alteogen Inc., Clearside BioMedical, Inc., Formycon AG, Regeneron Pharmaceuticals Inc, ThromboGenics NV and Chengdu Kanghong Pharmaceuticals Group Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Placenta Growth Factor market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Placenta Growth Factor and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Placenta Growth Factor sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Placenta Growth Factor market size, projected growth trends, production technologies, key applications, and end-use industries.

Placenta Growth Factor Segment by Company

Alteogen Inc.

Clearside BioMedical, Inc.

Formycon AG

Regeneron Pharmaceuticals Inc

ThromboGenics NV

Chengdu Kanghong Pharmaceuticals Group Co Ltd

Placenta Growth Factor Segment by Type

SL-186

SL-188

Aflibercept

Aflibercept Biosimilar

Others

Placenta Growth Factor Segment by Application

Neovascular Glaucoma

Myopia

Branch Retinal Vein Occlusion

Others

Placenta Growth Factor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Placenta Growth Factor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Placenta Growth Factor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Placenta Growth Factor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Placenta Growth Factor market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Placenta Growth Factor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Placenta Growth Factor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Placenta Growth Factor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Placenta Growth Factor Industry Trends Table 2. Placenta Growth Factor Industry Drivers Table 3. Placenta Growth Factor Industry Opportunities and Challenges Table 4. Placenta Growth Factor Industry Restraints Table 5. Global Placenta Growth Factor Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Placenta Growth Factor Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Placenta Growth Factor Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Placenta Growth Factor Sales Market Share by Manufacturers Table 9. Global Placenta Growth Factor Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Placenta Growth Factor Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Placenta Growth Factor Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Placenta Growth Factor Manufacturers, Product Type & Application Table 13. Global Placenta Growth Factor Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Placenta Growth Factor by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of SL-186 Table 17. Major Manufacturers of SL-188 Table 18. Major Manufacturers of Aflibercept Table 19. Major Manufacturers of Aflibercept Biosimilar Table 20. Major Manufacturers of Others Table 21. Global Placenta Growth Factor Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Placenta Growth Factor Sales by Type (2021-2026) & (k units) Table 23. Global Placenta Growth Factor Sales by Type (2027-2032) & (k units) Table 24. Global Placenta Growth Factor Sales Market Share by Type (2021-2026) Table 25. Global Placenta Growth Factor Sales Market Share by Type (2027-2032) Table 26. Global Placenta Growth Factor Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Placenta Growth Factor Revenue by Type (2021-2026) & (k units) Table 28. Global Placenta Growth Factor Revenue by Type (2027-2032) & (k units) Table 29. Global Placenta Growth Factor Revenue Market Share by Type (2021-2026) Table 30. Global Placenta Growth Factor Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Neovascular Glaucoma Table 32. Major Manufacturers of Myopia Table 33. Major Manufacturers of Branch Retinal Vein Occlusion Table 34. Major Manufacturers of Others Table 35. Global Placenta Growth Factor Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Placenta Growth Factor Sales by Application (2021-2026) & (k units) Table 37. Global Placenta Growth Factor Sales by Application (2027-2032) & (k units) Table 38. Global Placenta Growth Factor Sales Market Share by Application (2021-2026) Table 39. Global Placenta Growth Factor Sales Market Share by Application (2027-2032) Table 40. Global Placenta Growth Factor Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Placenta Growth Factor Revenue by Application (2021-2026) & (k units) Table 42. Global Placenta Growth Factor Revenue by Application (2027-2032) & (k units) Table 43. Global Placenta Growth Factor Revenue Market Share by Application (2021-2026) Table 44. Global Placenta Growth Factor Revenue Market Share by Application (2027-2032) Table 45. Global Placenta Growth Factor Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Placenta Growth Factor Sales by Region (2021-2026) & (k units) Table 47. Global Placenta Growth Factor Sales Market Share by Region (2021-2026) Table 48. Global Placenta Growth Factor Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Placenta Growth Factor Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Placenta Growth Factor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Placenta Growth Factor Sales by Country (2021-2026) & (k units) Table 52. North America Placenta Growth Factor Sales by Country (2027-2032) & (k units) Table 53. Europe Placenta Growth Factor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Placenta Growth Factor Sales by Country (2021-2026) & (k units) Table 55. Europe Placenta Growth Factor Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Placenta Growth Factor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Placenta Growth Factor Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Placenta Growth Factor Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Placenta Growth Factor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Placenta Growth Factor Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Placenta Growth Factor Sales by Country (2027-2032) & (k units) Table 62. Global Placenta Growth Factor Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Placenta Growth Factor Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Placenta Growth Factor Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Placenta Growth Factor Revenue Market Share by Region (2021-2026) Table 66. Global Placenta Growth Factor Revenue Market Share by Region (2027-2032) Table 67. Alteogen Inc. Company Information Table 68. Alteogen Inc. Business Overview Table 69. Alteogen Inc. Placenta Growth Factor Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Alteogen Inc. Placenta Growth Factor Product Portfolio Table 71. Alteogen Inc. Recent Development Table 72. Clearside BioMedical, Inc. Company Information Table 73. Clearside BioMedical, Inc. Business Overview Table 74. Clearside BioMedical, Inc. Placenta Growth Factor Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Clearside BioMedical, Inc. Placenta Growth Factor Product Portfolio Table 76. Clearside BioMedical, Inc. Recent Development Table 77. Formycon AG Company Information Table 78. Formycon AG Business Overview Table 79. Formycon AG Placenta Growth Factor Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Formycon AG Placenta Growth Factor Product Portfolio Table 81. Formycon AG Recent Development Table 82. Regeneron Pharmaceuticals Inc Company Information Table 83. Regeneron Pharmaceuticals Inc Business Overview Table 84. Regeneron Pharmaceuticals Inc Placenta Growth Factor Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Regeneron Pharmaceuticals Inc Placenta Growth Factor Product Portfolio Table 86. Regeneron Pharmaceuticals Inc Recent Development Table 87. ThromboGenics NV Company Information Table 88. ThromboGenics NV Business Overview Table 89. ThromboGenics NV Placenta Growth Factor Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. ThromboGenics NV Placenta Growth Factor Product Portfolio Table 91. ThromboGenics NV Recent Development Table 92. Chengdu Kanghong Pharmaceuticals Group Co Ltd Company Information Table 93. Chengdu Kanghong Pharmaceuticals Group Co Ltd Business Overview Table 94. Chengdu Kanghong Pharmaceuticals Group Co Ltd Placenta Growth Factor Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Chengdu Kanghong Pharmaceuticals Group Co Ltd Placenta Growth Factor Product Portfolio Table 96. Chengdu Kanghong Pharmaceuticals Group Co Ltd Recent Development Table 97. Key Raw Materials Table 98. Raw Materials Key Suppliers Table 99. Placenta Growth Factor Distributors List Table 100. Placenta Growth Factor Customers List Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Placenta Growth Factor Product Image Figure 2. Global Placenta Growth Factor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Placenta Growth Factor Market Size (2021-2032) & (US$ Million) Figure 4. Global Placenta Growth Factor Sales (2021-2032) & (k units) Figure 5. Global Placenta Growth Factor Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Placenta Growth Factor Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. SL-186 Image Figure 9. SL-188 Image Figure 10. Aflibercept Image Figure 11. Aflibercept Biosimilar Image Figure 12. Others Image Figure 13. Global Placenta Growth Factor Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Placenta Growth Factor Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Placenta Growth Factor Sales Market Share by Type (2021-2032) Figure 16. Global Placenta Growth Factor Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Placenta Growth Factor Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Placenta Growth Factor Revenue Market Share by Type (2021-2032) Figure 19. Neovascular Glaucoma Image Figure 20. Myopia Image Figure 21. Branch Retinal Vein Occlusion Image Figure 22. Others Image Figure 23. Global Placenta Growth Factor Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Placenta Growth Factor Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Placenta Growth Factor Sales Market Share by Application (2021-2032) Figure 26. Global Placenta Growth Factor Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Placenta Growth Factor Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Placenta Growth Factor Revenue Market Share by Application (2021-2032) Figure 29. North America Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Placenta Growth Factor Sales Market Share by Country (2021-2032) Figure 31. U.S. Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Placenta Growth Factor Sales Market Share by Country (2021-2032) Figure 36. Germany Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Placenta Growth Factor Sales Market Share by Country (2021-2032) Figure 43. China Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Placenta Growth Factor Sales Market Share by Country (2021-2032) Figure 51. Brazil Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Placenta Growth Factor Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Placenta Growth Factor Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Placenta Growth Factor Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Placenta Growth Factor Revenue (2021-2032) & (US$ Million) Figure 62. North America Placenta Growth Factor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Placenta Growth Factor Revenue (2021-2032) & (US$ Million) Figure 64. Europe Placenta Growth Factor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Placenta Growth Factor Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Placenta Growth Factor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Placenta Growth Factor Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Placenta Growth Factor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Placenta Growth Factor Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Placenta Growth Factor Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • SL-186
  • SL-188
  • Aflibercept
  • Aflibercept Biosimilar
  • Others
Applications
  • Neovascular Glaucoma
  • Myopia
  • Branch Retinal Vein Occlusion
  • Others
Companies covered
  • Alteogen Inc.
  • Clearside BioMedical, Inc.
  • Formycon AG
  • Regeneron Pharmaceuticals Inc
  • ThromboGenics NV
  • Chengdu Kanghong Pharmaceuticals Group Co Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Placenta Growth Factor Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Placenta Growth Factor Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Placenta Growth Factor Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Placenta Growth Factor Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Placenta Growth Factor Market Dynamics
  1. 2.1 Placenta Growth Factor Industry Trends
  2. 2.2 Placenta Growth Factor Industry Drivers
  3. 2.3 Placenta Growth Factor Industry Opportunities and Challenges
  4. 2.4 Placenta Growth Factor Industry Restraints
3 Placenta Growth Factor Market by Manufacturers
  1. 3.1 Global Placenta Growth Factor Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Placenta Growth Factor Sales by Manufacturers (2021-2026)
  3. 3.3 Global Placenta Growth Factor Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Placenta Growth Factor Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Placenta Growth Factor Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Placenta Growth Factor Manufacturers, Product Type & Application
  7. 3.7 Global Placenta Growth Factor Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Placenta Growth Factor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Placenta Growth Factor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Placenta Growth Factor Tier 1, Tier 2, and Tier 3
4 Placenta Growth Factor Market by Type
  1. 4.1 Placenta Growth Factor Type Introduction
  2. 4.1.1 SL-186
  3. 4.1.2 SL-188
  4. 4.1.3 Aflibercept
  5. 4.1.4 Aflibercept Biosimilar
  6. 4.1.5 Others
  7. 4.2 Global Placenta Growth Factor Sales by Type
  8. 4.2.1 Global Placenta Growth Factor Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Placenta Growth Factor Sales by Type (2021-2032)
  10. 4.2.3 Global Placenta Growth Factor Sales Market Share by Type (2021-2032)
  11. 4.3 Global Placenta Growth Factor Revenue by Type
  12. 4.3.1 Global Placenta Growth Factor Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Placenta Growth Factor Revenue by Type (2021-2032)
  14. 4.3.3 Global Placenta Growth Factor Revenue Market Share by Type (2021-2032)
5 Placenta Growth Factor Market by Application
  1. 5.1 Placenta Growth Factor Application Introduction
  2. 5.1.1 Neovascular Glaucoma
  3. 5.1.2 Myopia
  4. 5.1.3 Branch Retinal Vein Occlusion
  5. 5.1.4 Others
  6. 5.2 Global Placenta Growth Factor Sales by Application
  7. 5.2.1 Global Placenta Growth Factor Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Placenta Growth Factor Sales by Application (2021-2032)
  9. 5.2.3 Global Placenta Growth Factor Sales Market Share by Application (2021-2032)
  10. 5.3 Global Placenta Growth Factor Revenue by Application
  11. 5.3.1 Global Placenta Growth Factor Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Placenta Growth Factor Revenue by Application (2021-2032)
  13. 5.3.3 Global Placenta Growth Factor Revenue Market Share by Application (2021-2032)
6 Global Placenta Growth Factor Sales by Region
  1. 6.1 Global Placenta Growth Factor Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Placenta Growth Factor Sales by Region (2021-2032)
  3. 6.2.1 Global Placenta Growth Factor Sales by Region (2021-2026)
  4. 6.2.2 Global Placenta Growth Factor Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Placenta Growth Factor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Placenta Growth Factor Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Placenta Growth Factor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Placenta Growth Factor Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Placenta Growth Factor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Placenta Growth Factor Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Placenta Growth Factor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Placenta Growth Factor Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Placenta Growth Factor Revenue by Region
  1. 7.1 Global Placenta Growth Factor Revenue by Region
  2. 7.1.1 Global Placenta Growth Factor Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Placenta Growth Factor Revenue by Region (2021-2026)
  4. 7.1.3 Global Placenta Growth Factor Revenue by Region (2027-2032)
  5. 7.1.4 Global Placenta Growth Factor Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Placenta Growth Factor Revenue (2021-2032)
  8. 7.2.2 North America Placenta Growth Factor Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Placenta Growth Factor Revenue (2021-2032)
  11. 7.3.2 Europe Placenta Growth Factor Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Placenta Growth Factor Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Placenta Growth Factor Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Placenta Growth Factor Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Placenta Growth Factor Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alteogen Inc.
  2. 8.1.1 Alteogen Inc. Company Information
  3. 8.1.2 Alteogen Inc. Business Overview
  4. 8.1.3 Alteogen Inc. Placenta Growth Factor Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alteogen Inc. Placenta Growth Factor Product Portfolio
  6. 8.1.5 Alteogen Inc. Recent Developments
  7. 8.2 Clearside BioMedical, Inc.
  8. 8.2.1 Clearside BioMedical, Inc. Company Information
  9. 8.2.2 Clearside BioMedical, Inc. Business Overview
  10. 8.2.3 Clearside BioMedical, Inc. Placenta Growth Factor Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Clearside BioMedical, Inc. Placenta Growth Factor Product Portfolio
  12. 8.2.5 Clearside BioMedical, Inc. Recent Developments
  13. 8.3 Formycon AG
  14. 8.3.1 Formycon AG Company Information
  15. 8.3.2 Formycon AG Business Overview
  16. 8.3.3 Formycon AG Placenta Growth Factor Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Formycon AG Placenta Growth Factor Product Portfolio
  18. 8.3.5 Formycon AG Recent Developments
  19. 8.4 Regeneron Pharmaceuticals Inc
  20. 8.4.1 Regeneron Pharmaceuticals Inc Company Information
  21. 8.4.2 Regeneron Pharmaceuticals Inc Business Overview
  22. 8.4.3 Regeneron Pharmaceuticals Inc Placenta Growth Factor Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Regeneron Pharmaceuticals Inc Placenta Growth Factor Product Portfolio
  24. 8.4.5 Regeneron Pharmaceuticals Inc Recent Developments
  25. 8.5 ThromboGenics NV
  26. 8.5.1 ThromboGenics NV Company Information
  27. 8.5.2 ThromboGenics NV Business Overview
  28. 8.5.3 ThromboGenics NV Placenta Growth Factor Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ThromboGenics NV Placenta Growth Factor Product Portfolio
  30. 8.5.5 ThromboGenics NV Recent Developments
  31. 8.6 Chengdu Kanghong Pharmaceuticals Group Co Ltd
  32. 8.6.1 Chengdu Kanghong Pharmaceuticals Group Co Ltd Company Information
  33. 8.6.2 Chengdu Kanghong Pharmaceuticals Group Co Ltd Business Overview
  34. 8.6.3 Chengdu Kanghong Pharmaceuticals Group Co Ltd Placenta Growth Factor Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Chengdu Kanghong Pharmaceuticals Group Co Ltd Placenta Growth Factor Product Portfolio
  36. 8.6.5 Chengdu Kanghong Pharmaceuticals Group Co Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Placenta Growth Factor Value Chain Analysis
  2. 9.1.1 Placenta Growth Factor Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Placenta Growth Factor Production Mode & Process
  6. 9.2 Placenta Growth Factor Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Placenta Growth Factor Distributors
  9. 9.2.3 Placenta Growth Factor Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst